NeuroDerm
Presence
Mitsubishi Tanabe Pharma is a company listed under the stock ticker 4508 (JP).
Mitsubishi Tanabe Pharma has a direct presence in 4 countries.Mitsubishi Tanabe Pharma has 5 subsidiaries including API Corporation, Mitsubishi Tanabe Pharma America and Mitsubishi Tanabe Pharma Development America.
Executives
View the org chart displaying its 13 main executives
Most searched biographies at NeuroDerm
- Kengo Isshiki, Chief Executive Officer
- Yasutoshi Kawakami, Chairman of the Board
- Mikio Himizu, Director
Create your alert
to follow the executive moves at NeuroDerm.
Pharmaceuticals
Mitsubishi Tanabe Pharma has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by NeuroDerm
- Positive Results from Phase 3 BouNDless Trial Evaluating ND0612 in Parkinson’s Disease Patients with Motor Fluctuations
- World Parkinson’s Day (WPD) - April 11th 2023
- News and Events
- Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson’s Disease Patients with Motor Fluctuations
- Press Releases – Page 2 – NeuroDerm
- Press Releases – NeuroDerm
- Press Releases – NeuroDerm
- Press Releases – NeuroDerm
- Press Releases – NeuroDerm
- View more press releases Close
Social media about NeuroDerm
- NeuroDerm on Wikipedia, Google News & Yahoo Finance
- NeuroDerm on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Kengo Isshiki 
